Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (641-650 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysisKim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
Fibroblast Activation Protein-Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational TrialLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Ebiomedicine|May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIANStefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
Journal of Medical Internet Research|September 6, 2024
Establishing Medical Intelligence-Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation StudyAlexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?Andrei Gafita, Hui Wang, Andrew Robertson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
The Future of Nuclear Medicine, Molecular Imaging, and TheranosticsWolfgang A Weber, Johannes Czernin, Carolyn J Anderson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Pageof 73

Showing results (641-650 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2025
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Christoph E Heilig, Eva Wardelmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysisKim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
Fibroblast Activation Protein-Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational TrialLukas Kessler, Felix Schwaning, Martin Metzenmacher, et al.
Ebiomedicine|May 21, 2025
Combined [<sup>18</sup>F]Fluorodeoxyglucose PET and [<sup>123</sup>I]Iodometomidate-SPECT for diagnostic evaluation of indeterminate adrenal neoplasias-the cross-sectional diagnostic test accuracy study FAMIANStefanie Hahner, Philipp Hartrampf, Felix Beuschlein, et al.
Journal of Medical Internet Research|September 6, 2024
Establishing Medical Intelligence-Leveraging Fast Healthcare Interoperability Resources to Improve Clinical Management: Retrospective Cohort and Clinical Implementation StudyAlexander Brehmer, Christopher Martin Sauer, Jayson Salazar Rodríguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?Andrei Gafita, Hui Wang, Andrew Robertson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
The Future of Nuclear Medicine, Molecular Imaging, and TheranosticsWolfgang A Weber, Johannes Czernin, Carolyn J Anderson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2024
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, <sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Lukas Kessler, Tobias Blau, et al.
Pageof 73